推薦產(chǎn)品
3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazole 2-(chloromethyl)-3-methylpyridinehydrochloride 1-(2-bromo-4-methylphenyl)ethanone 3-chloroisoquinoline-4-carbonitrile 5,8-dichloropyrido[3,2-d]pyridazine 2-bromomalononitrile 2-(4-(bromomethyl)phenyl)benzo[d]thiazole 1-(bromomethyl)-3-methoxy-2-nitrobenzene 6-bromo-1H-[1,2,3]triazolo[4,5-b]pyridine 4-iodo-2-((trimethylsilyloxy)methyl)thiazole 6-iodoimidazo[1,2-a]pyridine-3-carbonitrile 2-(4-chlorophenyl)-2-morpholinoacetonitrile 4-chloro-7H-pyrrolo[2,3-d]pyrimidine 4-chloroisothiazole 5-bromo-6-chloro-1H-indole 7-chloro-3H-imidazo[4,5-b]pyridine ethyl3-(4-formylphenyl)propanoate 2,3-dibromobenzaldehyde 1-(5H-chromeno[2,3-b]pyridin-7-yl)ethanone 5H-chromeno[2,3-b]pyridin-5-one 3-chloroisoquinoline-4-carbaldehyde (E)-2-(3-oxoprop-1-enyl)benzaldehyde methyl4-formyl-3-nitrobenzoate 5,6-dimethoxy-2,2-dimethyl-2,3-dihydro-1H-inden-1-one 1-methylbicyclo[4.1.0]heptan-3-one 3-nitro-4-(trifluoromethoxy)benzaldehyde 2-hydroxyquinoline-6-carbaldehyde 2-nitro-3-(trifluoromethyl)benzaldehyde 1-(2-fluoro-4-methoxyphenyl)propan-2-one tert-butyl3-fluoro-4-oxopiperidine-1-carboxylate tert-butyl3-oxopropylcarbamate 2,2-dimethylcyclohexanone 9H-carbazole-3-carbaldehyde N,N-dimethyl-2-oxoacetamide 2-methylpent-4-yn-2-ol 3-tert-butyl-4-hydroxybenzonitrile 4-bromo-2-tert-butylphenol 1,3-dibutoxypropan-2-ol methyl4-hydroxyquinoline-6-carboxylate methyl3-cyano-4-hydroxybenzoate 4-chloro-6-methoxyquinolin-7-ol 3,4-dihydro-2H-benzo[b][1,4]oxazin-7-ol 2-(2-aminothiazol-5-yl)ethanolhydrochloride (R)-ethyl2-chloropropanoate (S)-4-amino-5-(4,4-dimethylcyclohexylamino)-5-oxopentanoicacid (1s,4s)-4-hydroxycyclohexanecarboxylicacid (S)-2-(tetrahydrofuran-3-yloxy)aceticacid (1S,4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-enol (R)-4-(hydroxymethyl)oxazolidin-2-one (S)-4-(hydroxymethyl)oxazolidin-2-one 化工資訊 目前正值藥市銷售旺季，也是多數(shù)家種藥材產(chǎn)新上市高峰。由于整體行情低迷，大貨購銷不如2013年，購貨商多小心翼翼，隨購隨銷成為當(dāng)前藥市主流趨勢。隨新貨上市貨源不斷增加，而市場銷售量不見放大，低價(jià)反彈只是一廂情愿，不過，低價(jià)還是引起不少商家關(guān)注，壓貨商不輕舉妄動(dòng)，常年經(jīng)營戶不管價(jià)高價(jià)低還是需要正常購貨的，以此托住一些藥材價(jià)格難以繼續(xù)回落。
面對(duì)當(dāng)前藥市一片低迷，我們也不能坐以待斃，更不能坐吃山空。建議尋找一兩個(gè)品種做長期經(jīng)營，總結(jié)行情規(guī)律，尋找藥市商機(jī)。對(duì)于從高價(jià)跌落的藥材可以關(guān)注，但不可盲目行動(dòng)。這些藥材之所以從高價(jià)跌落，就是由于供大于求。在生產(chǎn)沒有調(diào)減下來，庫存沒有得到良好消化之前，一年半載不會(huì)出現(xiàn)大的商機(jī)。人為的購買囤積，帶動(dòng)價(jià)格反彈只是短期行情表現(xiàn)，難改長期低迷趨勢。等這些掉價(jià)藥材行情平穩(wěn)了，估計(jì)價(jià)格觸底了，便可以購貨正常經(jīng)營，也許不出3-5年就會(huì)有不小的收獲。
“花開堪折直須折，莫待無花空折枝。”不錯(cuò)過一次買賣機(jī)會(huì)，因?yàn)闄C(jī)會(huì)稍縱即逝。只是機(jī)會(huì)未來臨時(shí)，要靜如皓月當(dāng)空。一旦機(jī)會(huì)來臨，也要?jiǎng)尤琊I虎捕食。如何抓住買賣機(jī)會(huì)？冰凍三日非一日之寒，不經(jīng)過幾次行情的大漲大落，很難把脈起伏不定的藥市行情。
